Antidiabetic drugs, including metformin, gliflozins, and incretin analogs, represent current therapeutic strategies for the prediabetic state, aimed at impairing the progression to DM and reducing the related morbidity and mortality rates (Table 1) [149,150]. The gene discussed is GCG; the disease is diabetes mellitus.